These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16138882)

  • 21. Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.
    Zipse MM; Tzou WS
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1361-1366. PubMed ID: 28670752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden cardiac death: mechanisms, therapies and challenges.
    Winslow RD; Mehta D; Fuster V
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):352-60. PubMed ID: 16265561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden death in nondilated cardiomyopathies: pathophysiology and prevention.
    Soni A; LeLorier P
    Curr Heart Fail Rep; 2005 Sep; 2(3):118-23. PubMed ID: 16138947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmogenic right ventricular cardiomyopathy.
    Hamilton RM
    Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S44-51. PubMed ID: 19602162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmogenic forms of heart failure in children.
    Berger S; Dubin AM
    Heart Fail Clin; 2010 Oct; 6(4):471-81, viii. PubMed ID: 20869647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-associated cardiomyopathy etiopathogenesis and clinical aspects.
    Barbaro G
    Herz; 2005 Sep; 30(6):486-92. PubMed ID: 16170679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvolt T-wave alternans testing for ventricular arrhythmia risk stratification.
    Chow T; Joshi D
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):833-42. PubMed ID: 18570621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden cardiac death.
    Sra J
    Indian Heart J; 1999; 51(2):137-59. PubMed ID: 10407542
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sports death--an Internal Medicine problem?].
    Sack S
    Herz; 2004 Jun; 29(4):414-9. PubMed ID: 15241541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cardiomyopathies: mortality, sudden death, and ventricular arrhythmias.
    Leier CV
    Cardiovasc Clin; 1992; 22(1):275-306. PubMed ID: 1728430
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary].
    Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C
    Rev Esp Cardiol; 2006 Dec; 59(12):1328. PubMed ID: 17194428
    [No Abstract]   [Full Text] [Related]  

  • 36. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
    Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arrhythmogenic right ventricular cardiomyopathy.
    Pike R
    Can J Cardiovasc Nurs; 2009; 19(2):5-9. PubMed ID: 19517899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy.
    Cha YM; Gersh BJ; Maron BJ; Boriani G; Spirito P; Hodge DO; Weivoda PL; Trusty JM; Friedman PA; Hammill SC; Rea RF; Shen WK
    J Cardiovasc Electrophysiol; 2007 May; 18(5):483-7. PubMed ID: 17343723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.